Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7097493rdf:typepubmed:Citationlld:pubmed
pubmed-article:7097493lifeskim:mentionsumls-concept:C0039771lld:lifeskim
pubmed-article:7097493lifeskim:mentionsumls-concept:C0039225lld:lifeskim
pubmed-article:7097493lifeskim:mentionsumls-concept:C1706947lld:lifeskim
pubmed-article:7097493pubmed:issue5lld:pubmed
pubmed-article:7097493pubmed:dateCreated1982-9-10lld:pubmed
pubmed-article:7097493pubmed:abstractTextIn dissolution studies of whole and halved 100-mg sustained-release theophylline tablets, drug release from halved tablets was significantly higher. These differences were not reflected in the bioavailability studies. The area under the curve (AUC) mean absorption time and fraction-of-dose recovered in urine at 24 hr were not significantly different following the ingestion of whole or halved 100-mg tablets. The elimination rate constant, half-life, volume of distribution, plasma, and renal clearance values were consistent with values reported previously. Discrepancies were found in the 24-hr metabolite distribution as compared to literature values and may be accounted for by the age and health of the subjects and the frequency of dosing.lld:pubmed
pubmed-article:7097493pubmed:languageenglld:pubmed
pubmed-article:7097493pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7097493pubmed:citationSubsetIMlld:pubmed
pubmed-article:7097493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7097493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7097493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7097493pubmed:statusMEDLINElld:pubmed
pubmed-article:7097493pubmed:monthMaylld:pubmed
pubmed-article:7097493pubmed:issn0022-3549lld:pubmed
pubmed-article:7097493pubmed:authorpubmed-author:SimonsK JKJlld:pubmed
pubmed-article:7097493pubmed:authorpubmed-author:SimonsF EFElld:pubmed
pubmed-article:7097493pubmed:authorpubmed-author:FrithE MEMlld:pubmed
pubmed-article:7097493pubmed:issnTypePrintlld:pubmed
pubmed-article:7097493pubmed:volume71lld:pubmed
pubmed-article:7097493pubmed:ownerNLMlld:pubmed
pubmed-article:7097493pubmed:authorsCompleteYlld:pubmed
pubmed-article:7097493pubmed:pagination505-11lld:pubmed
pubmed-article:7097493pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:meshHeadingpubmed-meshheading:7097493-...lld:pubmed
pubmed-article:7097493pubmed:year1982lld:pubmed
pubmed-article:7097493pubmed:articleTitleDissolution and bioavailability studies of whole and halved sustained-release theophylline tablets.lld:pubmed
pubmed-article:7097493pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7097493pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed